Olmatan 40mg (Olmesartan Medoxomil)

Adult dose

The recommended initial dose is 10mg once daily, taken regardless of meals. If blood pressure is not adequately controlled, the dose can be increased to 20mg once daily. The maximum dose can be increased to 40mg once daily. Blood pressure lowering effects appear within 2 weeks after starting treatment, with maximum effects occurring in about 8 weeks. If blood pressure is not controlled with this medication alone, it can be combined with thiazide diuretics. For patients over 65 years of age

Child dose

The safety and efficacy in children have not been established.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication, pregnant or nursing women, patients on kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, and those with lactose intolerance should not take this medication. Patients with low blood volume or sodium may experience symptoms of low blood pressure when first taking this medication, so careful monitoring is required, and appropriate actions should be taken if low blood pressure occurs. Patients with impaired kidney function, kidney transplant recipients, or patients with renovascular hypertension should periodically check kidney function and serum potassium levels while taking this medication. Due to the risk of hyperkalemia, individuals with heart failure or kidney disorders should have their serum potassium levels frequently assessed, and should take precautions when engaging in dangerous tasks or driving because dizziness may occur. Mild side effects like dizziness have been reported in clinical trials targeting hypertensive patients while rare cases of skin rash or angioedema may occur. If severe diarrhea or weight loss occurs while taking this medication, consult a doctor, and if symptoms similar to chronic malabsorption appear, discontinuation may be necessary. Taking concurrently with potassium-sparing diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, etc., may elevate blood potassium levels or impact kidney function, hence informing the physician and exercising caution is advised. During pregnancy, this medication should be avoided for the health of the fetus, and during breastfeeding, consideration of discontinuation or stopping breastfeeding may be necessary to avoid effects on the baby. Safety in children has not been established, so it is advisable not to use in children. In case of overdose, symptoms of low blood pressure and palpitations may occur, and if symptoms are severe, immediate medical attention should be sought. This medication is known to have a low risk of carcinogenicity or genotoxicity even with prolonged use, but it should be taken with caution.

Serious side effects

Urticaria, severe swelling (including facial edema, angioedema), chest pain (including chest tightness), difficulty breathing (including asthma, asthma attacks), cold sweat, pallor, severe rash with high fever, blisters, peeling of skin, pain in mucous membranes of mouth/eyes, yellowing of skin or eyes (jaundice), general weakness, general lethargy, severe liver abnormalities (including autoimmune hepatitis), sudden and severe headache, lightning-like headache, seizures,

Mild side effects

• Dizziness
• headache
• palpitations
• back pain
• bronchitis
• increased creatine phosphokinase
• diarrhea
• hematuria
• hyperglycemia
• hypertriglyceridemia

This medication should be stored in a tightly closed container to protect it from air and moisture. The appropriate storage temperature is a cool place between 1°C and 25°C.

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle